| Literature DB >> 6383919 |
S Srikanta, O P Ganda, R A Jackson, S J Brink, E Fleischnick, E Yunis, C Alper, J S Soeldner, G S Eisenbarth.
Abstract
In an ongoing prospective study 32 individuals have been evaluated for insulin secretory dynamics, islet cell antibodies and HLA antigens, during the preclinical phase of Type 1 diabetes mellitus. Twenty-four out of the 32 subjects were islet cell antibody-positive. To date, 14 subjects (10 islet cell antibody-positive, four islet cell antibody-negative) have progressed to develop overt diabetes. Several patterns of HLA-DR expression were noted (DR3/DR4, DR3/DR3, DR3/x, DR3/DR1, DR4/x, DR4/DR7, DR5/DR7, DR1/DR7 and DR1/DR2). Irrespective of differences in islet cell antibody status or HLA-DR alleles, pre-diabetic individuals exhibited a similar slow course of progressive beta-cell dysfunction.Entities:
Mesh:
Substances:
Year: 1984 PMID: 6383919 DOI: 10.1007/bf00275674
Source DB: PubMed Journal: Diabetologia ISSN: 0012-186X Impact factor: 10.122